Impact of the Nature and Interface of the Tracheostomy Cannula on Dyspnea in Patients Weaning From Artificial Ventilation in Weaning Unit

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris

About this trial

This trial aims to assess dyspnea intensity in tracheostomized patients undergoing prolonged artificial ventilation weaning. The primary outcome is dyspnea measured by the Visual Analogue Scale (VAS-Dyspnea). A comparison between low-pressure balloon tracheostomy cannula and plated balloon cannula and four interfaces (Cap, ventilator, phonation valve, or filter) are tested. The secondary outcomes including Multidimensional Dyspnea Profile, pain, anxiety VAS, and tolerance under different interfaces. The multicenter, cross-over study involves 76 patients over 25 months, each serving as their own control. Cap is always evaluated first but the order of the three interfaces (ventilator, phonation valve, or filter) and type of cannula are chosen by randomization. The study is conducted in three weaning centers (SRPR units) at Pitié-Salpêtrière, Bligny, and Forcilles.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patient aged 18 years or older

Patient admitted to SRPR with respiratory and hemodynamic stability

Patient with a tracheostomy tube

Deflated balloon for more than 6 hours per day

Disqualifiers

Pregnant women (verified by a blood or urine test during hospitalization for all women of childbearing age)

Patients deprived of liberty or under legal protection (guardianship or curatorship)

Patients unable to consent to the research

Contraindication to the use of a 7 mm tracheostomy tube

Trial design

Design model

Crossover

Treatments tested in this trial

  • low pressure tracheostomy cannulas

    Device

    The tracheostomy tube is changed according to the randomization sequence, a filter is connected for 5 minutes; then baseline data will be assessed. The tracheostomy tube is then connected to the four interfaces for 30 minutes each. Parameters is measured after each 30-minute period. The cuff of the tracheostomy tube will be deflated using a syringe when the interface is a filter, phonation valve, or cap. In contrast, the cuff will be inflated when the interface is the ventilator. The cuff is inflated with a manometer for the low-pressure balloon tracheostomy tube and with the minimum and sufficient amount of injectable water for the plated balloon tracheostomy tube to avoid overpressure

  • plated balloon tracheostomy cannulas

    Device

    The tracheostomy tube is changed according to the randomization sequence, a filter is connected for 5 minutes; then baseline data will be assessed. The tracheostomy tube is then connected to the four interfaces for 30 minutes each. Parameters is measured after each 30-minute period. The cuff of the tracheostomy tube will be deflated using a syringe when the interface is a filter, phonation valve, or cap. In contrast, the cuff will be inflated when the interface is the ventilator. The cuff is inflated with a manometer for the low-pressure balloon tracheostomy tube and with the minimum and sufficient amount of injectable water for the plated balloon tracheostomy tube to avoid overpressure

Treatment groups

76 Participants
are divided into 2 treatment groups
Group A: plated balloon tracheostomy cannulasExperimental treatment 2 interventions
Group B: low pressure balloon tracheotomy cannulasActive comparator 2 interventions

Trial outcomes

Primary outcomes

1

Dyspnea visual analogic scale (VAS) with cap

The VAS of dyspnoea evaluate the severity of dyspnoea, the index has 10 numerical values, rated on a scale from 0-10, each value corresponding to an intensity of breathlessness. It is an easy-to-use scale for patients.

Time frame
30 minutes after using each interfaces

Secondary outcomes

1

Dyspnea visual analogic scale (VAS) after 30 min breathing with filter, ventilator and phonation valve

The VAS of dyspnoea evaluate the severity of dyspnoea, the index has 10 numerical values, rated on a scale from 0-10, each value corresponding to an intensity of breathlessness. It is an easy-to-use scale for patients.

Time frame
30 minutes after using each interfaces
2

Multidimensional Dyspnea Profile (MDP)

The Multidimensional Dyspnea Profile (MDP) assesses overall breathing discomfort, sensory qualities, and emotional responses

Time frame
30 minutes after using each interfaces
3

Biological variable : Heart rate

Heart rate (beat per minute)

Time frame
30 minutes after using each interfaces
4

Biological variable : Respiratory rate

Respiratory rate (cycles per minute)

Time frame
30 minutes after using each interfaces

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: